Trial Profile
Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Children
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Apr 2013
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary)
- Indications Influenza A virus H5N1 subtype
- Focus Pharmacodynamics